Children's Cold and Allergy Medicines Recalled
Author: Ian C. Langtree - Writer/Editor for Disabled World (DW)
Published: 1 May 2010
Contents: Synopsis - Introduction - Main - Related Publications
Synopsis: Recall has been issued for more than 40 over-the-counter drugs for children including Tylenol and Motrin.
Introduction
A voluntary recall has been issued for more than 40 over-the-counter drugs for children, including Tylenol and Motrin, because they don't meet quality standards.Main Content
"This recall is not being undertaken on the basis of adverse medical events," McNeil Consumer Healthcare said in a statement Friday. "However, as a precautionary measure, parents and caregivers should not administer these products to their children."
"Some products in the recall may have a higher concentration of active ingredient than specified while others may have inactive ingredients that don't meet testing requirements, the company said.
The company said it issued the recall after consulting with the Food and Drug Administration. The affected brands include: Tylenol Infants' Drops, Children's Tylenol Suspensions, Children's Tylenol Plus Suspensions, Motrin Infant Drops, Children's Motrin Suspensions, Children's Zyrtec Liquids in Bottles and Children's Benadryl Allergy Liquids in Bottles.
The drugs were made in the United States and distributed to Canada, the Dominican Republic, Dubai, Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad & Tobago and Kuwait.
Author Credentials: Ian is the founder and Editor-in-Chief of Disabled World, a leading resource for news and information on disability issues. With a global perspective shaped by years of travel and lived experience, Ian is a committed proponent of the Social Model of Disability-a transformative framework developed by disabled activists in the 1970s that emphasizes dismantling societal barriers rather than focusing solely on individual impairments. His work reflects a deep commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his full biography.